Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
03 October 2019 | Story Ruan Bruwer | Photo Gallo Images
Lappies Labuschagne
Lappies Labuschagné got his first rugby contract with the Cheetahs after impressing for the Shimlas. He is now playing for Japan – the first Shimla to do so.

Former Shimla Lappies Labuschagné made his ex-coach Jaco Swanepoel proud when he was recently included in the Japan Rugby World Cup (RWC) squad.

Labuschagné, made his debut for Japan on 28 September as captain shortly before the tournament, which is currently under way there, then led Japan to a historic win over Ireland, the world’s fourth-ranked team.


Labuschagné has been playing his rugby in Japan since 2016. Previously, he played for the Shimlas between 2009 and 2012 and captained the team in 2012. At that time, Swanepoel was the head coach of the Shimlas. 

“I’m extremely glad that he got his chance to play in the World Cup, just to prove that he can compete at that level. It was wonderful to see the leadership we knew he had on Saturday,” Swanepoel said.

He believes Labuschagné was unlucky not to have played for the Springboks. In 2013, he was called up to the South African squad, but failed to force his way into the congested Springbok back row. 

“Subjectivity in team selection was the reason that he wasn’t considered. He deserved to be selected and he worked extremely hard. I don’t know of a player who worked harder than him. Nobody wanted to work out with him in the gymnasium, because he always put in extra effort. That made him special.”

Swanepoel describes Labuschagné as a “very special person”.

“Lappies the human being is perhaps a little bit better than Lappies the rugby player.”  

“Hopefully we can get a Japan rugby jersey from him to display in the Shimla room soon,” Swanepoel added.

Labuschagné isn’t the only former Kovsie at the RWC. In the Springbok management team, Rassie Erasmus (head coach), Jacques Nienaber (defence coach), and Vivian Verwant (physiotherapist) are also former Kovsies.


News Archive

Otorhinolaryngology research hopes to decrease morbidity
2016-10-04

Description: Prof Riaz Seedat Tags: Prof Riaz Seedat

Prof Riaz Seedat, Head of the
Department of
Otorhinolaryngology at the UFS

Prof Riaz Seedat, Head of the Department of Otorhinolaryngology at the UFS is a world-renowned ear, nose and throat specialist and researcher. He is also a National Research Foundation C3 rated scientist.

He is conducting his research in ear, nose and throat (ENT) pathology in a developing world setting, particularly focusing on recurrent respiratory papillomatosis and other ENT conditions. “This condition is caused by human papillomavirus (HPV), infective conditions as well as allergic rhinitis,” said Prof Seedat.

Current research is aimed at further describing the epidemiology of recurrent respiratory papillomatosis, identification of the HPV variants responsible for causing the condition and markers of disease aggressiveness.

The research has led to various international partnerships such as the multicentre collaborative studies, “Genetic Susceptibility to Papilloma-induced Voice Disturbance” at the Centre for Genomic Sciences at the Allegheny-Singer Research Institute in Pittsburgh, United States, and the HPV6/11 Global Diversity Consortium at the University of Ljubljana in Slovenia.

Although most head and neck squamous cell carcinomas are caused by excessive tobacco and alcohol use, there is an increasing body of evidence to show that HPV causes a subset of head and neck squamous cell carcinomas. However, there are few studies on the role of HPV in head and neck neoplasms in developing countries.

“Through the research we have shown that recurrent respiratory papillomatosis, caused by HPV, is not as rare in South Africa as it is in developed countries and that patients usually present respiratory papillomatosis at an advanced stage when the condition is life-threatening,” said Prof Seedat.

“It is hoped that this research will help us to address the morbidity caused by ENT conditions common in developing countries,” said Prof Seedat.

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept